跳至主要内容
临床试验/JPRN-UMIN000021783
JPRN-UMIN000021783未知1 期

A prospective study which assess the safety and efficiacy of haploidentical hematopoietic stem cell transplantation using posttransplant cyclophosphamide for adult T cell leukemia/lymphoma - Haplo for AT

ational Cancer Center Hospital0 个研究点目标入组 17 人开始时间: 2016年4月5日最近更新:
适应症

试验速览

阶段
1 期
入组人数
17

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18years-old 至 65years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients who meet any criteria below are ineligible (1) severe organ failure (2) uncontrolled hypertension (3) HIV infection (4) uncontrolled infection (5) uncontrolled CNS invasion (6) pregnant/lactating (7) psychological disorder (8) known allergy for drugs used as GVHD prophylaxis or conditioning regimen (9) history of administration of anti-CCR4 antibody (10) high titer of anti-donor specific HLA antibody (11) the physician considers inappropriate for this study

研究者

相似试验